✦ LIBER ✦

Long-Term Results Following Switch From Abciximab to Eptifibatide During Percutaneous Coronary Intervention

✍ Scribed by Michael Koutouzis; Bo Lagerqvist; Jonas Oldgren; Axel Åkerblom; Magnus Wahlin; Thomas Karlsson; Per Albertsson; Göran Matejka; Lars Grip

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Switch from abciximab to eptifibatide du

✍ Magnus Wahlin; Per Albertsson; Thomas Karlsson; Göran Matejka; Annika Odell; Far 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 261 KB

Abciximab reduces long-term mortality fo

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Long-term mortality after bolus-only adm

✍ Jonathan D. Marmur; Shyam Poludasu; Jason Lazar; Erdal Cavusoglu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

Eptifibatide Is Noninferior to Abciximab

✍ Axel Åkerblom; Stefan K. James; Michail Koutouzis; Bo Lagerqvist; Ulf Stenestran 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 480 KB

Coronary Artery Bypass Surgery Provides

✍ Franklin L. Rosenfeldt; Mark D. Wilson; Brian F. Buxton; Silvana F. Marasco 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 729 KB

Comparison of Abciximab Versus Eptifibat

✍ Harsimran S. Singh; George D. Dangas; Giulio Guagliumi; Jennifer Yu; Bernhard Wi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 680 KB